Skip to main content Accessibility help
×
Home
Hostname: page-component-684899dbb8-7wlv9 Total loading time: 0.196 Render date: 2022-05-20T02:29:54.928Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "useNewApi": true }

The Effects of Risperidone vs Haloperidol on Cognitive Functioning in Treatment-Resistant Schizophrenia: The Trail Making Test

Published online by Cambridge University Press:  07 November 2014

Abstract

In this article, data are presented from Parts A and B of the Trail Making Test, which examined the effects of haloperidol vs risperidone on cognitive function in treatment-resistant scxhizophrenic patients. This report focuses on findings from the Trail Making Test. Overall, risperidone had a positive effect on Trail Making Part B performance following 4 weeks of treatment. These effects were due, at least in part, to the direct effects of risperidone. The possibility that an antipsychotic agent can enhance executive functioning through direct mechanisms, perhaps mediated by frontal cortex neurochemistry, indicates that the evaluation of antipsychotic medications in the treatment of schizophrenia should be expanded to include cognition.

Type
Feature Article
Copyright
Copyright © Cambridge University Press 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Goldberg, TE, Berman, KF, Weinberger, DR. Neuropsychology and neurophysiology of schizophrenia. Curr Opin Psychiatry. 1995;8:3440.CrossRefGoogle Scholar
2.Saykin, AJ, Schtasel, DL, Gur, RE, et al.Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch Gen Psychiatry. 1994:51:124131.CrossRefGoogle ScholarPubMed
3.Cassens, G, Inglis, AK, Appelbaum, PS, Gutheil, TG. Neuroleptics: effects on neuropsychological function in chronic schizophrenia patients. Schizophr Bull. 1990:16:477499.CrossRefGoogle Scholar
4.Spohn, HE, Strauss, ME. Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. J Abnorm Psychol. 1989:98:367380.CrossRefGoogle Scholar
5.Bersani, G, Bressa, GM, Meco, G, Marinis, S, Pozzi, F. Combined serotonin-5-HT2 and dopamine-D2 antagonism in schizophrenia: clinical, extrapyramidal and neuroendocrine response in a preliminary study with risperidone. Hum Psychopharmacol. 1990:5:225231.CrossRefGoogle Scholar
6.Marder, SR, Meibach, RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry. 1994:151:825835.Google ScholarPubMed
7.Green, MF. What are the functional consequences of neurocognitive deficits in schizophrenia. Am J Psychiatry. 1996:153:321330.Google Scholar
8.Green, MF, Marshall, BD, Wirshing, WC, et al.Does risperidone improve verbal working memory in treatment-resistant schizophrenia?Am J Psychiatry. 1997; In press.Google Scholar
9.Trestman, RL, Keefe, RS, Mitropoulou, V, et al.Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder. Psychiatry Res. 1995:58:127136.CrossRefGoogle Scholar
10.Fredericks, RS, Finkel, P. Schizophrenic performance on the Halstead-Reitan Battery. J Clin Psychol. 1978:34:2630.3.0.CO;2-Q>CrossRefGoogle ScholarPubMed
11.Simon, SH. The effects of tranquilizers on the Trail Making Test with chronic schizophrenic patients. Journal ol Consulting Psychology (J Consult Clin Psychcol). 1967:31:322323.Google Scholar
12.Kane, J, Honigfeld, G, Singer, J, Meltzer, H, Group, CCS. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988:45:789796.CrossRefGoogle ScholarPubMed
13.Altman, HJ, Normile, HJ. What is the nature of the role of the serotonergic nervous system in learning and memory: prospects for development of an effective treatment strategy for senile dementia. Neurobiol Aging. 1988:9:627638.CrossRefGoogle ScholarPubMed
14
Cited by

Save article to Kindle

To save this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

The Effects of Risperidone vs Haloperidol on Cognitive Functioning in Treatment-Resistant Schizophrenia: The Trail Making Test
Available formats
×

Save article to Dropbox

To save this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about saving content to Dropbox.

The Effects of Risperidone vs Haloperidol on Cognitive Functioning in Treatment-Resistant Schizophrenia: The Trail Making Test
Available formats
×

Save article to Google Drive

To save this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about saving content to Google Drive.

The Effects of Risperidone vs Haloperidol on Cognitive Functioning in Treatment-Resistant Schizophrenia: The Trail Making Test
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *